• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

GW Cancer receives $4 million award for technical assistance to comprehensive cancer control

Bioengineer by Bioengineer
March 27, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Principal Investigator Mandi Pratt-Chapman, MA has been awarded a $4.125 million cooperative agreement to continue work with the Centers for Disease Control and Prevention (CDC) to provide comprehensive technical assistance for National Comprehensive Cancer Control Program (NCCCP) grantees. These programs are in all 50 states, Washington, D.C., eight tribes and tribal organizations, and seven U.S. Associated Pacific Islands/territories. The new five-year award is a competitive renewal of the successful $2.1 million awarded from 2013 to 2018.

The cooperative agreement expands technical assistance efforts by leveraging the existing infrastructure, capacity and relationships of the talent at the institute for patient centered initiatives & health equity, a division of the GW Cancer Center, to provide support to NCCCP grantees. NCCCP grantees create stakeholder-driven plans that aim to reduce the burden of cancer through evidence-based cancer control interventions adapted to local settings, including efforts to advance access to screening, treatment, and cancer survivorship care and to reduce health inequities.

The GW Cancer Center’s strategies include:

    – Improved mechanisms of communication and coordination

    – Web-based professional education and training with continuing education credits

    – Development, maintenance and dissemination of tools and resources

    – Identification and dissemination of successful policy, systems, and environmental changes

    – Coalition-building and strategic planning for NCCCPs

    – Live workshops focused on American Indian tribes and Pacific Island Jurisdiction needs

“The GW Cancer Center is pleased to continue supporting Comprehensive Cancer Control programs through this award. I am extremely proud of the technical assistance team. CDC’s renewal of our work demonstrates the high value placed on our tailored, multi-level strategies to advance cancer control and reduce health inequities across the nation,” said Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at the GW Cancer Center. “We look forward to another strong half decade with this exciting and rewarding project.”

The five-year project will receive $825,000 per year, totaling $4.125 million after five years of funding, subject to availability of funds. The project is 100 percent federally financed, with zero percent of financing from non-government sources.

###

Media Contact
Lisa Anderson
[email protected]
https://cancercenter.gwu.edu/news/investigator-receives-4125-million-award-continue-technical-assistance-comprehensive-cancer

Tags: cancerHealth CareHealth Care Systems/ServicesHealth ProfessionalsMedicine/HealthPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

PARP1 Drives Neuropathic Pain Through GPX4-Dependent Ferroptosis in Injured Mice’s Sensory Neurons

August 15, 2026

Genome-wide skin pQTL map reveals genetic regulators and mechanisms underlying skin disorders

August 15, 2026

Levistilide A Drives Ferroptosis via RNF40-HSP90α Axis, Suppressing Colorectal Cancer Lung Metastasis

August 15, 2026

Sintilimab, IBI305, and Chemotherapy Show Promise in First-Line Advanced Gastric and GEJ Adenocarcinoma

August 15, 2026
Please login to join discussion

POPULAR NEWS

  • KAIST develops semiconductor neuron that harnesses noise to selectively process signals

    29 shares
    Share 12 Tweet 7
  • Imagining natural and extra robotic thumbs together strengthens kinesthetic sensorimotor networks

    29 shares
    Share 12 Tweet 7
  • PARP1 Drives Neuropathic Pain Through GPX4-Dependent Ferroptosis in Injured Mice’s Sensory Neurons

    29 shares
    Share 12 Tweet 7
  • Strubbelig–NHL3 Receptor Complex Helps Arabidopsis Respond to Cellulose Deficiency

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

KAIST develops semiconductor neuron that harnesses noise to selectively process signals

Imagining natural and extra robotic thumbs together strengthens kinesthetic sensorimotor networks

PARP1 Drives Neuropathic Pain Through GPX4-Dependent Ferroptosis in Injured Mice’s Sensory Neurons

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.